Loperamide induced cardiac arrhythmia successfully supported with veno-arterial ECMO (VA-ECMO), molecular adsorbent recirculating system (MARS) and continuous renal replacement therapy (CRRT)

Brandon Masi ParkerDivision of Critical Care Medicine, University of Maryland School of Medicine, R Adams Cowley Shock Trauma Center, University of Maryland Medical Center, Baltimore, MD, USACorrespondence[email protected]

http://orcid.org/0000-0002-3935-1276

Tejaus RaoDivision of Critical Care Medicine, University of Maryland School of Medicine, R Adams Cowley Shock Trauma Center, University of Maryland Medical Center, Baltimore, MD, USA

Ann MattaDivision of Critical Care Medicine, University of Maryland School of Medicine, R Adams Cowley Shock Trauma Center, University of Maryland Medical Center, Baltimore, MD, USA

Megan QuitannaDivision of Critical Care Medicine, University of Maryland School of Medicine, R Adams Cowley Shock Trauma Center, University of Maryland Medical Center, Baltimore, MD, USA

H. Neal ReynoldsDivision of Critical Care Medicine, University of Maryland School of Medicine, R Adams Cowley Shock Trauma Center, University of Maryland Medical Center, Baltimore, MD, USA

Deborah M SteinDivision of Critical Care Medicine, University of Maryland School of Medicine, R Adams Cowley Shock Trauma Center, University of Maryland Medical Center, Baltimore, MD, USA

Daniel HaaseDivision of Critical Care Medicine, University of Maryland School of Medicine, R Adams Cowley Shock Trauma Center, University of Maryland Medical Center, Baltimore, MD, USA

http://orcid.org/0000-0001-8950-1933

show all

Abstract

Introduction: This case of Loperamide misuse had refractory ventricular arrhythmias and was successfully supported by VA ECMO. Loperamide is currently available without prescription and can be obtained in large quantities over the internet despite Food and Drug Administration (FDA) 2016 black box warning noting cardiac toxicity. This case illustrates the life-threatening toxicity of loperamide and suggests a supportive modality to provide clinical time while the drug is cleared endogenously or exogenously.

Case report: A 36-year-old female was found minimally responsive. Vital signs and monitoring revealed wide complex bradycardia, undetectable blood pressure, hypothermia, bradypnea, and hypoglycemia. The rhythm degenerated to polymorphic ventricular tachycardia cardia refractory to multiple ACLS protocols. VA-ECMO was initiated with immediate stabilization. Subsequent history revealed massive consumption of loperamide taking 400–600 mg daily. Highest known loperamide and N-desmethyl-loperamide levels were 32 and 500 ng/ml respectively. Since loperamide and metabolites are known to be protein bound, molecular adsorbent recirculating system (MARS) was initiated for toxin clearance. Additionally, she developed acute renal failure supported by CRRT. She was ultimately weaned from ECMO, MARS, and CRRT and discharged neurologically intact on hospital day 12.

Discussion: VA ECMO for hemodynamic support provided the needed time for natural resolution of the cardiac toxicity while providing adequate perfusion. MARS was used in the setting of highly protein bound toxins, but drug clearance could not be demonstrated through serial levels. VA ECMO (or referral to a center with VA ECMO) should be considered with lethal loperamide-induced cardiotoxicity and perhaps other cardio-toxins.

Keywords:

Disclosure statement

No potential conflict of interest was reported by the authors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Loperamide induced cardiac arrhythmia successfully supported with veno-arterial ECMO (VA-ECMO), molecular adsorbent recirculating system (MARS) and continuous renal replacement therapy (CRRT)

Information for

Open access

Opportunities

Help and information

Loperamide induced cardiac arrhythmia successfully supported with veno-arterial ECMO (VA-ECMO), molecular adsorbent recirculating system (MARS) and continuous renal replacement therapy (CRRT)

Abstract

Disclosure statement

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature